Zahra Masoumi

Dr. Zahra Masoumi

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2015 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
MFMary Familari
Mary Familari
TCTina Cronqvist
Tina Cronqvist
ZMZahra Masoumi
Zahra Masoumi
SHStefan R. Hansson
Stefan R. Hansson
The literature on extracellular vesicles consists of rapidly expanding and often contradictory information. In this paper we attempt to review what is currently known regarding extracellular vesicles released specifically from human placental syncytiotrophoblast cells with a focus on the common but complex pregnancy-associated syndrome pre-eclampsia, where the level of syncytiotrophoblast extracellular vesicle release is significantly increased. We review common methods for syncytiotrophoblast extracellular vesicle derivation and isolation and we discuss the cargo of syncytiotrophoblast extracellular vesicles including proteins, RNA and lipids and their possible functions. A meta-analysis of available trophoblast-derived extracellular vesicle proteomic datasets revealed only three proteins in common: albumin, fibronectin-1 and plasminogen activator inhibitor-1, suggesting some variability in vesicle cargo, most likely reflecting stage and cell type of origin. We discuss the possible sources of variability that may have led to the low number of common markers, which has led us to speculate that markers and density in common use may not be strict criteria for identifying and isolating placenta-derived exosomes.

20 December 2012 in ISRN Microbiology
Verified
Journal Article
Open access
PDF file
SHSeyed Asghar Havaei
Seyed Asghar Havaei
AAAmir Azimian
Amir Azimian
HFHosein Fazeli
Hosein Fazeli
MNMahmood Naderi
Mahmood Naderi
KGKiarash Ghazvini
Kiarash Ghazvini
MAMojtaba Akbari
Mojtaba Akbari
Background. Global concerns have been raised due to upward trend of Vancomycin Intermediate Staphylococcus aureus (VISA) and Vancomycin Resistant Staphylococcus aureus (VRSA) reports which mean casting doubt on the absolute effectiveness of the last line of antibiotic treatment for S. aureus, vancomycin. Hence, epidemiological evaluation can improve global health care policies. Methodology. 171 Isolates of Staphylococcus aureus were collected from different types of clinical samples in selected hospitals in Isfahan, Mashhad, and Tehran, Iran. Then, they were evaluated by agar screening, disk diffusion, and MIC method to determine their resistance to vancomycin and methicillin. The isolated VISA strains were then confirmed with genetic analysis by the evaluation of mecA and vanA genes, SCCmec, agr, and spa type, and also toxin profiles. MLST was also performed. Results and Conclusion. Our data indicated that 67% of isolated S. aureus strains were resistant to methicillin. Furthermore, five isolates (2.9%) had intermediate resistance to vancomycin (VISA). In contrast to usual association of VISA with MRSA strains, we found two isolates of MSSA-VISA. Therefore, our data suggests a probable parallel growing trend of VISA towards MSSA, along with MRSA strains. However, more samples are required to confirm these primarily data. Moreover, genetic analysis of the isolated VISA strains revealed that these strains are endemic Asian clones.

23 November 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
MHMaryam Hafizi
Maryam Hafizi
AHAtena Hajarizadeh
Atena Hajarizadeh
AAAmir atashi
Amir atashi
SKSomayeh Kalanaky
Somayeh Kalanaky
SFSaideh Fakharzadeh
Saideh Fakharzadeh
MSMasoud Soleimani
Masoud Soleimani
Introduction: Human mesenchymal stem cells (hMSCs) have been approved for therapeutic applications. Despite the advances in this field, in vitro approaches are still required to improve the essential indices that would pave the way to a bright horizon for an efficient transplantation in the future. Nanotechnology could help to improve these approaches. Studies signified the important role of iron in stem cell metabolism and efficiency of copper chelation application for stem cell expansion Methods: For the first time, based on novel Nanochelating technology, we design an iron containing copper chelator nano complex, GFc7 and examined on hMSCs during in vitro expansion. In this study, the hMSCs were isolated, characterized and expanded in vitro in two media (with or without GFc7). Then proliferation, cell viability, cell cycle analysis, surface markers, HLADR, pluripotency genes expression, homing and antioxidative defense at genes and protein expression were investigated. Also we analyzed the spontaneous differentiation and examined osteogenic and lipogenic differentiation. Results: GFc7 affected the expression of key genes, improving both the stemness and fitness of the cells in a precise and balanced manner. We observed significant increases in cell proliferation, enhanced expression of pluripotency genes and homing markers, improved antioxidative defense, repression of genes involved in spontaneous differentiation and exposing the hMSCs to differentiation medium indicated that pretreatment with GFc7 increased the quality and rate of differentiation. Conclusions: Thus, GFc7 appears to be a potential new supplement for cell culture medium for increasing the efficiency of transplantation.

11 July 2017 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
VTVahideh Tarhriz
Vahideh Tarhriz
KWKay‐Dietrich Wagner
Kay‐Dietrich Wagner
ZMZahra Masoumi
Zahra Masoumi
OMOmmoleila Molavi
Ommoleila Molavi
MHMohammad Saeid Hejazi
Mohammad Saeid Hejazi
HGHossein Ghanbarian
Hossein Ghanbarian

1 May 2013 in Vaccine
Verified
Journal Article
Closed access
SFSaideh Fakharzadeh
Saideh Fakharzadeh
SKSomayeh Kalanaky
Somayeh Kalanaky
MHMaryam Hafizi
Maryam Hafizi
MGMohammad Mahdi Goya
Mohammad Mahdi Goya
ZMZahra Masoumi
Zahra Masoumi
MNMohammad Hassan Nazaran
Mohammad Hassan Nazaran

28 April 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZMZahra Masoumi
Zahra Masoumi
MFMary Familari
Mary Familari
KKKarin Källén
Karin Källén
JRJonas Ranstam
Jonas Ranstam
POPer Olofsson
Per Olofsson
SHStefan R. Hansson
Stefan R. Hansson
Preeclampsia (PE) is associated with increased fetal hemoglobin (HbF) in the maternal circulation but its source is unknown. To investigate whether excessive HbF is produced in the placenta or the fetus, the concentration of HbF (cHbF) in the arterial and venous umbilical cord blood (UCB) was compared in 15825 normotensive and 444 PE pregnancies. The effect of fetal gender on cHbF was also evaluated in both groups. Arterial and venous UCB sampled immediately after birth at 36–42 weeks of gestation were analyzed for total Hb concentration (ctHb) (g/L) and HbF% using a Radiometer blood gas analyzer. Non-parametric tests were used for statistical comparison and P values < 0.05 were considered significant. Our results indicated higher cHbF in venous compared to arterial UCB in both normotensive (118.90 vs 117.30) and PE (126.75 vs 120.12) groups. In PE compared to normotensive pregnancies, a significant increase was observed in arterial and venous ctHb (171.00 vs 166.00 and 168.00 vs 163.00, respectively) while cHbF was only significantly increased in venous UCB (126.75 vs 118.90). The pattern was similar in both genders. These results indicate a substantial placental contribution to HbF levels in UCB, which increases in PE and is independent of fetal gender, suggesting the elevated cHbF evident in PE results from placental dysfunction.